PROTECTIVE EFFECTS OF PROPIONYL-L-CARNITINE DURING ISCHEMIA AND REPERFUSION

被引:32
|
作者
SHUG, A
PAULSON, D
SUBRAMANIAN, R
REGITZ, V
机构
[1] UNIV WISCONSIN,SCH MED,MADISON,WI 53706
[2] SCH OSTEOPATH MED,CHICAGO,IL
[3] HERZZENTRUM,BERLIN,GERMANY
关键词
PROPIONYL-L-CARNITINE; ISCHEMIA; REPERFUSION FATTY ACIDS; FREE RADICALS;
D O I
10.1007/BF00128246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When cardiac function in isolated rat hearts was impaired by subject them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [21] PROTECTIVE EFFECT OF PROPIONYL-L-CARNITINE AGAINST PAF-INDUCED RAT PAW EDEMA
    CARUSO, A
    CUTULI, VMC
    DEBERNARDIS, E
    LEONARDI, G
    AMICOROXAS, M
    PHARMACOLOGICAL RESEARCH, 1995, 31 (01) : 67 - 72
  • [22] Propionyl-L-Carnitine Improves Endothelial Function, Microcirculation and Pain Management in Critical Limb Ischemia
    De Marchi, S.
    Zecchetto, S.
    Rigoni, A.
    Prior, M.
    Fondrieschi, L.
    Scuro, A.
    Rulfo, F.
    Arosio, E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (05) : 401 - 408
  • [23] Propionyl-L-Carnitine Improves Endothelial Function, Microcirculation and Pain Management in Critical Limb Ischemia
    S. De Marchi
    S. Zecchetto
    A. Rigoni
    M. Prior
    L. Fondrieschi
    A. Scuro
    F. Rulfo
    E. Arosio
    Cardiovascular Drugs and Therapy, 2012, 26 : 401 - 408
  • [24] EFFECT OF PROPIONYL-L-CARNITINE ON HUMAN ENDOTHELIAL-CELLS
    VANHINSBERGH, VWM
    SCHEFFER, MA
    CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 : 97 - 106
  • [25] The Investigators of the Study on Propionyl-L-Carnitine in Chronic Heart Failure
    Zhang Li-Zhen
    Chen Jie
    Zhang Znu-Lin
    CIRCULATION, 2010, 122 (02) : E230 - E230
  • [26] PROPIONYL-L-CARNITINE REDUCES PLASMA AMMONIA DURING EXERCISE IN PATIENTS WITH MCARDLES DISEASE
    WAGENMAKERS, AJM
    COAKLEY, JH
    EDWARDS, RHT
    ADVANCES IN MYOCHEMISTRY : 2, 1989, 2 : 195 - 195
  • [27] European multicenter study on propionyl-L-carnitine in intermittent claudication
    Brevetti, G
    Diehm, C
    Lambert, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) : 1618 - 1624
  • [28] Effect of propionyl-L-carnitine on quality of life in intermittent claudication
    Brevetti, G
    Perna, S
    Sabba, C
    Martone, VD
    Dilorio, A
    Barletta, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (06): : 777 - 780
  • [29] Propionyl-L-carnitine in NIDDM patients with peripheral vascular disease
    Federico, P
    Ragozzino, G
    Del Guercio, L
    Del Guercio, R
    PROCEEDINGS OF THE 14TH CONGRESS OF THE EUROPEAN CHAPTER OF THE INTERNATIONAL UNION OF ANGIOLOGY, 2001, : 321 - 328
  • [30] Propionyl-l-carnitine in intermittent claudication: Effect on quality of life
    Brevetti, G
    Martone, VD
    Sabba, C
    Perna, S
    DiLorio, A
    CIRCULATION, 1996, 94 (08) : 1372 - 1372